Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase III trial of 64Cu SARTATE for Positron Emission Tomography Imaging of Participants With Known or Suspected Neuroendocrine Tumours

Next Previous
X
Search
Trial Profile

A phase III trial of 64Cu SARTATE for Positron Emission Tomography Imaging of Participants With Known or Suspected Neuroendocrine Tumours

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 27 Dec 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs 64Cu-MeCOSar-Octreotate (Primary)
  • Indications Neuroendocrine tumours
  • Focus Diagnostic use; Registrational

    • Most Recent Events

    • 27 Dec 2024 New trial record
    • 28 Nov 2024 According to an Clarity Pharmaceuticals media release, the last patient has completed their final assessment in this trial. Final results from the DISCO study to be available in the first half of 2025, which will inform the design of registrational Phase III trial in this indication.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top